Evidence map›Paper›PMID 39677721›Full record

ArticlebioRxiv : the preprint server for biology2024

At-RS31 orchestrates hierarchical cross-regulation of splicing factors and integrates alternative splicing with TOR-ABA pathways.

Tino Köster, Peter Venhuizen, Martin Lewinski, Ezequiel Petrillo, Yamile Marquez, Armin Fuchs, Debashish Ray, Barbara A Nimeth, Stefan Riegler, Sophie Franzmeier and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Tino KösterRNA Biology and Molecular Physiology, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0003-3984-9813
Peter VenhuizenInstitute of Molecular Plant Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria.ORCID 0000-0003-2835-1833
Martin LewinskiRNA Biology and Molecular Physiology, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-2692-3319
Ezequiel PetrilloInstituto de Fisiología, Biología Molecular y Neurociencias (IFIBYNE), Buenos Aires, Argentina.ORCID 0000-0002-0025-3708
Yamile MarquezMax Perutz Labs, Medical University Vienna, Vienna BioCenter (VBC), 1030 Vienna, Austria.ORCID 0000-0003-1686-5992
Armin FuchsMax Perutz Labs, Medical University Vienna, Vienna BioCenter (VBC), 1030 Vienna, Austria.
Debashish RayDonnelly Centre, University of Toronto, Toronto, ON Canada.ORCID 0000-0003-2021-1115
Barbara A NimethInstitute of Molecular Plant Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria.
Stefan RieglerInstitute of Molecular Plant Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria.ORCID 0000-0003-3413-1343
Sophie FranzmeierInstitute of Molecular Plant Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria.ORCID 0000-0002-1265-6790
Hong ZhengDonnelly Centre, University of Toronto, Toronto, ON Canada.
Timothy HughesDonnelly Centre, University of Toronto, Toronto, ON Canada.ORCID 0000-0002-8721-4719
Quaid MorrisSloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-2760-6999
Andrea BartaMax Perutz Labs, Medical University Vienna, Vienna BioCenter (VBC), 1030 Vienna, Austria.ORCID 0000-0002-8851-406X
Dorothee StaigerRNA Biology and Molecular Physiology, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-1341-1381
Maria KalynaInstitute of Molecular Plant Biology, Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences (BOKU), 1190 Vienna, Austria.ORCID 0000-0003-4702-7625

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Post-transcriptional Regulatory NetworksR01HG013328 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI Quaid Morris · 2023 to 2026
$2.6M
Systematic characterization of unconventional RNA binding proteinsR01HG008613 · NHGRI · UNIVERSITY OF TORONTO · PI BLENCOWE, BENJAMIN, GREENBLATT, JACK · 2015 to 2017
$1.0M
NCI NIH HHS P30 CA008748NHGRI NIH HHS R01 HG008613NHGRI NIH HHS R01 HG013328
6 · The paper itself

Abstract

Alternative splicing is essential for plants, enabling a single gene to produce multiple transcript variants to boost functional diversity and fine-tune responses to environmental and developmental cues. At-RS31, a plant-specific splicing factor in the Serine/Arginine (SR)-rich protein family, responds to light and the Target of Rapamycin (TOR) signaling pathway, yet its downstream targets and regulatory impact remain unknown.To identify At-RS31 targets, we applied individual-nucleotide resolution crosslinking and immunoprecipitation (iCLIP) and RNAcompete assays. Transcriptomic analyses of At-RS31 mutant and overexpressing plants further revealed its effects on alternative splicing.iCLIP identified 4,034 At-RS31 binding sites across 1,421 genes, enriched in CU-rich and CAGA RNA motifs. Comparative iCLIP and RNAcompete data indicate that the RS domain of At-RS31 may influence its binding specificity

Indexed as

ABAalternative splicingArabidopsisbinding siteiCLIPRNAcompeteSR proteinsTOR kinase

Identifiers

PMID39677721
PMCPMC11643119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.